“It usually occurs soon after vaccination, and can be treated with epinephrine (as in an EpiPen),” explains Harvard Health. According to the NHS, you should tell healthcare staff before you are vaccinated if you’ve ever had a serious allergic reaction. “You should not have the COVID-19 vaccine if you have ever had a serious allergic… Read More »
LONDON — As many as 60 countries, including some of the world’s poorest, might be stalled at the first shots of their coronavirus vaccinations because nearly all deliveries through the global program intended to help them are blocked until as late as June. COVAX, the global initiative to provide vaccines to countries lacking the clout… Read More »
“The highest levels of NIH are very concerned,” said Dr. Avindra Nath, intramural clinical director and a leader of viral research at the National Institute for Neurological Disorders and Stroke, an NIH division. “Everyone’s hopes are on a vaccine, and if you have a major complication the whole thing could get derailed.” A great deal… Read More »
An employee draws up a syringe and a container with the BioNTech/Pfizer vaccine, in Schwaz, Austria. JOHANN GRODER | AFP | Getty Images LONDON — The European Union is “facing a serious situation” in rolling out Covid-19 shots, but it is “highly unfair” to accuse the bloc of vaccine nationalism, the region’s trade chief told… Read More »
People who have experienced anaphylactic reactions to vaccines are being urged to wait 30 minutes after receiving their COVID-19 vaccine, after Queensland rapidly shifted its advice. Queensland Health Minister Yvette D’Ath urged people who had previously experienced anaphylactic reactions to hold off on getting immunised on Wednesday, after the state reported four anaphylactic reactions. But… Read More »
The AstraZeneca-Oxford vaccine is not effective against moderate infections of the South Africa variant of the coronavirus, according to a new study that complicates the strategy for curbing the pandemic through immunization. A new study in the New England Journal of Medicine found that the vaccine had an efficacy of only 10.4% against mild-to-moderate cases… Read More »
Pharmaceutical and medical device giant Johnson & Johnson, Inc. (J&J) announced on February 28, 2021, plans to test its experimental Ad26.COV2.S vaccine for COVID-19 on infant children (including newborns), pregnant women and people with compromised immune systems. J&J did not include infants, pregnant women or the immunocompromised in the U.S. population in clinical trials on… Read More »